Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells

  • Min Lu
  • , Jiapeng Wang
  • , Yan Li
  • , Dmitriy Berenzon
  • , Xiaoli Wang
  • , John Mascarenhas
  • , Mingjiang Xu
  • , Ronald Hoffman

Research output: Contribution to journal › Article › peer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Treatment with the Bcl-xL inhibitor ABT-737 in combination with interferon α specifically targets JAK2V617F-positive polycythemia vera hematopoietic progenitor cells'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science